Free Trial
NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

Shuttle Pharmaceuticals logo
$1.67
-0.20 (-10.70%)
(As of 11/1/2024 ET)

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Key Stats

Today's Range
$1.65
$1.95
50-Day Range
$1.03
$2.37
52-Week Range
$1.03
$4.95
Volume
278,569 shs
Average Volume
3.30 million shs
Market Capitalization
$4.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.

Shuttle Pharmaceuticals Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
27th Percentile Overall Score

SHPH MarketRank™: 

Shuttle Pharmaceuticals scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Shuttle Pharmaceuticals is -0.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Shuttle Pharmaceuticals is -0.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Shuttle Pharmaceuticals has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Shuttle Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    1.67% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently decreased by 18.00%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Shuttle Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Shuttle Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.67% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently decreased by 18.00%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Shuttle Pharmaceuticals has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Shuttle Pharmaceuticals this week, compared to 0 articles on an average week.
  • Search Interest

    Only 4 people have searched for SHPH on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Shuttle Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Shuttle Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    39.60% of the stock of Shuttle Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.58% of the stock of Shuttle Pharmaceuticals is held by institutions.

  • Read more about Shuttle Pharmaceuticals' insider trading history.
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPH Stock News Headlines

Micro Cap Company Is Soaring On Phase 2 Trial Update
Tim Sykes’ Urgent Trade Alert: “Make this move now”
Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.
Shuttle Pharmaceuticals doses first patients in Phase 2 trial of Ropidoxuridine
Shuttle Pharma Pays Off Senior Secured Convertible Note
See More Headlines

SHPH Stock Analysis - Frequently Asked Questions

Shuttle Pharmaceuticals' stock was trading at $1.96 at the beginning of the year. Since then, SHPH shares have decreased by 14.8% and is now trading at $1.67.
View the best growth stocks for 2024 here
.

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) released its quarterly earnings data on Tuesday, September, 3rd. The company reported ($0.96) EPS for the quarter.

Shuttle Pharmaceuticals (SHPH) raised $10 million in an IPO on Wednesday, August 31st 2022. The company issued 1,225,888 shares at $8.13 per share.

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shuttle Pharmaceuticals investors own include Mullen Automotive (MULN), MSP Recovery (LIFW), MSP Recovery (LIFW), NIO (NIO), Tesla (TSLA), Broadcom (AVGO) and AMTD Digital (HKD).

Company Calendar

Last Earnings
9/03/2024
Today
11/02/2024
Next Earnings (Estimated)
11/11/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SHPH
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
$-6,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.03 per share

Miscellaneous

Free Float
1,779,000
Market Cap
$4.93 million
Optionable
Not Optionable
Beta
-1.33
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:SHPH) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners